Venus gets marketing nod from Venezuela

For meropenem

Venus Remedies has received marketing authorisation for meropenem from Venezuela, a $6 billion pharmaceutical market. The Company plans to lauch meropenem in Venezuela in the next couple of months.

Powered by Capital Market - Live News